study on Amukkara Chooranam for the management of mudakku vatham
Not Applicable
Completed
- Conditions
- Health Condition 1: M259- Joint disorder, unspecifiedHealth Condition 2: null- Patients having the symptoms ofRheumatoid Arthritis
- Registration Number
- CTRI/2017/02/007887
- Lead Sponsor
- Dr A Mariappan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 19
Inclusion Criteria
Symmetrical joint involvement
Arthritis of three or more joints
RA factor positive or negative
Morning stiffness
Deformities like swan neck deformity and button hole deformity
Swelling especially in the inter-phalangeal
joint
Exclusion Criteria
Pregnancy and lactation
Tubercular arthritis
Any other serious systemic illness
Osteoarthritis
Psoriatic arthritis
Gouty arthritis
Diabetes mellitus
Hypertension
Hyperlipidemia
Cardiac diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the therapeutic efficacy of siddha drug Amukkura chooranam in reducing the pain and restricted joint movements in the treatment of rheumatoid arthritisTimepoint: At the end of the treatment
- Secondary Outcome Measures
Name Time Method To study the siddha basic principles like Envagai thervu,Neerkuri and Neikuri,Udalthathukal,Uyirthathukal and Kaalam etc.,in Uthira vatha suronitham patients. <br/ ><br>To study the effect of Amukkura chooranam on levels of IL-1,IL-6,IL-10,IL-12,IL-4,IL-17,IL-23 and TNF-alfa in blood of Uthira vatha suronitham patients and thereby to elicit possible mechanism of action of the Amukkura chhooranam.Timepoint: At the end of the treatment